SEC 13F Intelligence

Worth Venture Partners, LLC / ADMSEUR

Worth Venture Partners, LLC’s Adamas Pharmaceuticals Inc Position

Does Worth Venture Partners, LLC own Adamas Pharmaceuticals Inc (ADMSEUR)? Not currently — the last reported position was 625.1K shares worth $3M in Q3 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$3M
Q3 2021
Shares
625.1K
% of Portfolio
+1.39%
Quarters Held
10
position exited

Position History ADMSEUR

Reported value by quarter
Q1 ’19: $425,000Q1 ’19Q2 ’19: $545,000Q3 ’19: $396,000Q3 ’19Q1 ’20: $454,000Q2 ’20: $624,000Q2 ’20Q3 ’20: $927,000Q4 ’20: $975,000Q4 ’20Q1 ’21: $3MQ2 ’21: $3MQ2 ’21Q3 ’21: $3Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 2021625.1K$3M+1.39%
Q2 2021590.7K$3M+1.16%
Q1 2021538.4K$3M+1.25%
Q4 2020225.1K$975,000+0.77%
Q3 2020225.1K$927,000+0.76%
Q2 2020243.7K$624,000+0.31%
Q1 2020157.1K$454,000+0.28%
Q3 201977.4K$396,000+0.23%
Q2 201987.9K$545,000+0.30%
Q1 201959.7K$425,000+0.24%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Worth Venture Partners, LLC’s full portfolio or all institutional holders of ADMSEUR.